About Bapu's Profile & Investment Preferences
Bapu is an investor from Navi Mumbai with 18 years of years of experiences in API Manufacturing, API Pharma Manufacturing and API Pharmaceuticals industry. Bapu is a Managing Director in a company which was established in 2015 with a team of 100 and annual turnover of INR 12.00 Cr. Bapu is looking to invest in Pharmaceutical Manufacturing, Veterinary, Healthcare & Pharmaceuticals (Other) etc in Mumbai, Pune, Ahmednagar and others. Bapu has invested/acquired earlier within the last 5 years.
PROFESSIONAL PROFILE
Managing Director from Navi Mumbai
Areas of Experience :
18 years of experience in API Manufacturing, API Pharma Manufacturing, API Pharmaceuticals, chemical, CRO, R&D, Biotech
BUSINESS INFORMATION
Business Name :
Available on request
Established in :
2015
Turnover / Sales :
INR 12.00 Cr
Employees :
100
PREFERENCES
Transaction Deal
type:
Buy
Lease
Distribution
Interested For:
Family business / Own Business
Investment Budget :
Up to INR 50.00 Cr
Investment Rationale :
Strategic Acquisition / Expansion
OTHER DETAILS ABOUT INVESTOR
Acquired / Invested in
other business in last 5 years :
Yes
Source of Financing :
Own/External Funding
A visionary leader with over 16 years of diverse research experience across industry and academia, both nationally and internationally, successfully established one of India’s fastest-growing Contract Research Organizations (CROs) in 2015. With a strong foundation in R&D, business strategy, and custom synthesis, he has driven remarkable growth, earning recognition for excellence in reference standards manufacturing in both domestic and international markets.
He has received multiple prestigious awards and fellowships for his contributions to science and healthcare, including national research fellowships and international accolades. His expertise spans novel technology development, catalyst design, green chemistry, continuous processes, and advanced analytical techniques.
Currently leading several scientific and pharmaceutical ventures, he also contributes as a board and research committee member across multiple academic institutions, fostering strong industry-academia collaborations. A frequent invited speaker at national and international platforms, he continues to shape innovation in the chemical and pharmaceutical sectors.